Advanced Mineral-Bioactive Complex for Skin Barrier Optimisation for Psoriasis-Prone Skin
In plain English
AI plain-English summaryPsoriasis-prone skin in body folds often resists standard steroid creams, and Gran Lab’s new mineral-based formula aims to treat it without those drugs. This matters because sensitive psoriasis—affecting 3–7% of the 30 million psoriasis sufferers worldwide—is notoriously hard to treat. Existing options have side-effects: 70% of patients report a major negative impact on quality of life, 50% develop treatment resistance, and 35% face intimacy issues. People of colour are misdiagnosed 52% more often, leading to poorer care. The current gap is a steroid-free topical that works across diverse skin types. If GL-1 Mineral Complex Pro succeeds, it could offer a non-corrosive, non-irritant alternative that outperforms conventional hydrocortisone. The formulation has already shown anti-oxidant and anti-inflammatory properties in lab tests. Because Gran Lab tested it on a range of skin colours and textures, the product could reduce misdiagnosis-driven disparities and give clinicians a reliable option for patients who currently cycle through failing treatments.
View original technical description
View the original record at the funder ↗
Related Research
Grants with similar aims, by meaning.
Original classification
Grant for R&DPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know